Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP1159793.RADgHvMpH8X-2pSQyI7jQpP8T2EPPYeFWT0EnQU6TK2qg130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP1159793.RADgHvMpH8X-2pSQyI7jQpP8T2EPPYeFWT0EnQU6TK2qg130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP1159793.RADgHvMpH8X-2pSQyI7jQpP8T2EPPYeFWT0EnQU6TK2qg130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP1159793.RADgHvMpH8X-2pSQyI7jQpP8T2EPPYeFWT0EnQU6TK2qg130_provenance.
- befree-2016 importedOn "2016-02-19" NP1159793.RADgHvMpH8X-2pSQyI7jQpP8T2EPPYeFWT0EnQU6TK2qg130_provenance.
- NP1159793.RADgHvMpH8X-2pSQyI7jQpP8T2EPPYeFWT0EnQU6TK2qg130_assertion wasGeneratedBy ECO_0000203 NP1159793.RADgHvMpH8X-2pSQyI7jQpP8T2EPPYeFWT0EnQU6TK2qg130_provenance.
- NP1159793.RADgHvMpH8X-2pSQyI7jQpP8T2EPPYeFWT0EnQU6TK2qg130_assertion wasDerivedFrom befree-2016 NP1159793.RADgHvMpH8X-2pSQyI7jQpP8T2EPPYeFWT0EnQU6TK2qg130_provenance.
- NP1159793.RADgHvMpH8X-2pSQyI7jQpP8T2EPPYeFWT0EnQU6TK2qg130_assertion SIO_000772 24588013 NP1159793.RADgHvMpH8X-2pSQyI7jQpP8T2EPPYeFWT0EnQU6TK2qg130_provenance.
- NP1159793.RADgHvMpH8X-2pSQyI7jQpP8T2EPPYeFWT0EnQU6TK2qg130_assertion evidence source_evidence_literature NP1159793.RADgHvMpH8X-2pSQyI7jQpP8T2EPPYeFWT0EnQU6TK2qg130_provenance.
- NP1159793.RADgHvMpH8X-2pSQyI7jQpP8T2EPPYeFWT0EnQU6TK2qg130_assertion description "[Drug targeting of fusion genes has proven to be an extremely effective therapeutic approach for cancers such as the recurrent BCR–ABL1 fusion in chronic myeloid leukaemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1159793.RADgHvMpH8X-2pSQyI7jQpP8T2EPPYeFWT0EnQU6TK2qg130_provenance.